Molecular Foundations: Ketamine and MDMA

$200 CAD + tax

Format: online, learn at your own pace

Instructors: Content was written in consultation with Dr. Joe Flanders, PhD, OPQ and Dr. Devon Christie, MD, CCFP, IFMCP, RTC

Duration: 8 hours

This course will bring you on a journey through the effects elicited by ketamine and MDMA on the body and mind as it relates to psychedelic-assisted therapy. The content developed for this course is based on current literature and research and analyzed through the lens of trauma and violence-informed care and through commitments to social justice, equity, dignity, inclusion, cultural safety, and humility.

In the course, you will learn about the dose ranges, indications, contraindications, and concomitant medications of ketamine and MDMA. You will also learn about some fundamental pharmacology and neurobiology as it relates to the administration of ketamine and MDMA in psychedelic-assisted therapy.

This program is open to health care providers and members of the general public looking to dive into the chemistry of these important molecules.

This course has been accredited through the Canadian Psychological Association (CPA), l'Ordre des psychologues du Québec (OPQ), and the Canadian Counselling and Psychotherapy Association (CCPA). This is applicable to regulated professionals.

This course can be completed at your own pace whenever it is most convenient for you, however the course must be completed within 1 year of your registration date. If the course is not completed after 1 year, you will not be eligible for a refund, and you will need to re-register.

Explore the molecular foundations of ketamine and MDMA

This set of two courses is geared towards those who want to learn more about the molecular structure of ketamine and MDMA. In each course, you will learn about the dose ranges, indications, contraindications, and concomitant medications of each psychedelic medicine. You will also learn about some fundamental pharmacology and neurobiology as it relates to the administration of psychedelic medicines in psychedelic-assisted therapy.

After this course, you'll be able to:

  • Apply pharmacological knowledge of ketamine and MDMA to the facilitation or development of a psychedelic-assisted therapy protocol in a clinical setting.

  • Compare the wide range of effects, side effects, effects of long-term use, and abuse potential of ketamine and MDMA.

  • Apply cultural safety and humility to the administration of ketamine and MDMA as part of psilocybin-assisted therapy in order to avoid cultural appropriation and cultural harm.

  • Screen clients and determine if ketamine and MDMA would be best suited for a given client or clinical presentation.

Meet your facilitators:

Dr. Joe Flanders PhD

Dr. Flanders is a psychologist and the Founder and Regional Director of Mindspace. He obtained his PhD in Clinical Psychology from McGill University and completed a postdoctoral fellowship at the University of Wisconsin-Madison. He is also an Assistant Professor (Professional) in the McGill University Psychology Department and the Vice President of Practitioner Training at Numinus Wellness. He is licensed with the Québec Order of Psychologists. In his active psychotherapy practice, he supports the healing of anxiety, depression, post-traumatic stress, work stress, relationship problems, and personal and spiritual growth. Joe has been trained to deliver psychedelic-assisted therapy through Numinus and the Multidisciplinary Association of Psychedelic Studies (MAPS). He also has extensive training in Internal Family Systems therapy (IFS), Cognitive Behaviour Therapy (CBT), Acceptance and Commitment Therapy (ACT), and mindfulness-based psychotherapy. He holds the Advanced Mindfulness-Based Cognitive Therapy (MBCT) Facilitation Certification from the Centre for Mindfulness Studies (CMS) and the Factor-Inwentash Faculty of Social Work at the University of Toronto (FIFSW) as well as the Advanced Mindfulness-Based Stress Reduction (MBSR) Facilitation Certification from the CMS. He is an approved MBSR mentor with CMS.

Joe Flanders

Dr. Devon Christie MD, CCFP, IFMCP, RTC

Dr. Christie is a clinical instructor with the UBC Department of Medicine and has a focused practice in chronic pain management. She is also a Registered Counsellor emphasizing Relational Somatic Therapy for trauma resolution, and a certified Mindfulness Based Stress Reduction teacher (UCSD). She is trained to deliver both MDMA-assisted psychotherapy for PTSD (MAPS USA) and KAT. She teaches for the California Institute of Integral Studies Certificate Program in Psychedelic Therapy and Research, the Integrative Psychiatry Institute Certificate Program in Psychedelic Assisted Therapy, and the ONCA Foundation Psychedelic Therapy program. She is a Principal Investigator and study therapist for a current Canadian MAPS PBC-sponsored 20-participant open-label clinical trial investigating MDMA-assisted psychotherapy for PTSD. Devon is the Medical and Therapeutic Services Director with Numinus Wellness Inc. and is a recognized speaker and expert on the potential for incorporating psychedelic assisted therapies in an improved health care model for the future.

Devon Christie

FAQs

  • Are there prerequisites for this course?
    • No, there are no prerequisites.
  • Will a certificate of completion be offered to participants?
    • Yes - for 4 hours per course (ketamine, MDMA)
  • Are there any live sessions in these courses?
    • No - the Molecular Foundations courses are entirely asynchronous and can be completed on your own schedule.
  • Can I join even if I live outside of Canada?
    • Yes – absolutely
  • Still have questions?

Refund Policy

If you are unable to attend the course, please send an e-mail confirming your cancellation to training@numinus.com. A 10% administration fee will be charged for any cancellations, based on the total cost of the course, plus tax. If you have any questions, please reach out to our team and we would be happy to support you.

Disclaimer

The continuing professional development program in no way promotes, condones, or facilitates illegal activity, and is strictly for educational and harm reduction purposes only. Please be aware that certain psychedelic substances still remain illegal in many jurisdictions, including Canada. This program and the contents of this website do not constitute medical advice and are not a substitute for professional medical advice and treatment.